Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Rogatsch, M; Schmid, J; Lax, S; Uranitsch, M; Schmid-Zalaudek, K; Giuffrida, R; Zalaudek, I.
Metastatic cutaneous apocrine adenocarcinoma responsive to the programmed cell death protein 1 inhibitor pembrolizumab.
Eur J Cancer. 2018; 90:146-148 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Schmid Johannes
Schmid-Zalaudek Karin
Zalaudek Iris
Altmetrics:

Dimensions Citations:

Plum Analytics:
Find related publications in this database (using NLM MeSH Indexing)
Adenocarcinoma - drug therapy
Adenocarcinoma - pathology
Aged, 80 and over -
Antibodies, Monoclonal, Humanized - therapeutic use
Antineoplastic Agents, Immunological - therapeutic use
Apocrine Glands - pathology
Humans -
Male -
Programmed Cell Death 1 Receptor - antagonists & inhibitors
Sweat Gland Neoplasms - drug therapy
Sweat Gland Neoplasms - pathology

© Med Uni Graz Impressum